Mark S. Schroeder, EVP, President Diagnostics & COO at LABORATORY CORP OF AMERICA HOLDINGS (LH), sold 10,096 shares at $218.45 ($2.2M) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Scheduled sale ($2.2M) by EVP, President Diagnostics & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $218.45 | 5,048 | $1.1M | 50.0% |
| 2 | $218.45 | 5,048 | $1.1M | 50.0% |
| Total | $218.45 avg | 10,096 | $2.2M | 100% |
| Filing → |
| LH | SELL | 2024-04-03 | $2.8M | — | Filing → |
| LH | SELL | 2023-05-22 | $325K | — | Filing → |
| LH | SELL | 2023-04-03 | $1.8M | — | Filing → |